BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//California Life Sciences - ECPv6.17.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.califesciences.org
X-WR-CALDESC:Events for California Life Sciences
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260914T090000
DTEND;TZID=America/Los_Angeles:20260914T130000
DTSTAMP:20260831T160054Z
CREATED:20260831T160054Z
LAST-MODIFIED:20260831T160054Z
UID:10001180-1789376400-1789390800@www.califesciences.org
SUMMARY:Thermo Fisher Mass Spec Symposium @ MBC Biolabs
DESCRIPTION:From Sample to Insight: Advancing Mass Spectrometry Workflow\nJoin us for a morning of mass spectrometry innovation\, practical workflows\, and emerging applications spanning sample preparation\, quantitative proteomics\, structural biology\, and biopharmaceutical research. \nHear from MS experts as they share practical approaches\, new technologies\, and advanced workflows designed to improve reproducibility\, quantitation\, and insights across biopharmaceutical research and drug discovery. \nAgenda:\n9:00am – 9:15am | Welcome & Opening Remarks \n9:15am – 9:45am | Yanan Yang\, Director of MS CenterMBC BioLabsMBC BioLabs Advanced MS Center Introduction \n9:45am – 10:15am | Jae Choi\, Ph.D.\, MBA\, Staff ScientistThermo Fisher ScientificAdvancing Mass Spectrometry Sample Preparation: Introducing New Solutions \n10:15am – 10:45am | Quoc Hoang\, Staff Scientist\, Sample PrepThermo Fisher ScientificSimplifying Mass Spectrometry Sample Preparation with the KingFisher Platform: High-Throughput Automation for Enhanced Reproducibility and Ease of Use \n10:45am – 11:00am | BREAKBreak & Networking \n11:00am – 11:30am | Jonathan Mcnally\, LCMS Technical Sales SpecialistThermo Fisher ScientificRecent Advancements in Mass Spectrometry for Biological Research \n11:30am – 12:00pm | Jae Choi\, Ph.D.\, MBA\, Staff ScientistThermo Fisher ScientificIntegrated HCP Enrichment and Heavy Peptides for Quantitative LC-MS of Critical HCPs \n12:00pm – 12:30pm | Weijing Liu\, Ph.D.\, Senior ManagerThermo Fisher ScientificStructural Biology Mass Spectrometry: Bridging Structure and Function in Drug Discovery \n12:30pm – 1:00pm | Lunch\, Networking & Meet the Experts \nCoffee\, snacks\, and Lunch will be provided \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/mass-spec-symposium-mbc-biolabs/
LOCATION:1030 Brittan Ave\, 1030 Brittan Ave\, San Carlos\, CA\, 94070\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260915T093000
DTEND;TZID=America/Los_Angeles:20260915T103000
DTSTAMP:20260806T202448Z
CREATED:20260806T202448Z
LAST-MODIFIED:20260806T202448Z
UID:10001146-1789464600-1789468200@www.califesciences.org
SUMMARY:When Lyocakes Go Bad - How to Identify & Fix It
DESCRIPTION:Join our webinar to discover how you can identify and fix any issues in your own batches. Using different examples of lyocake defects\, Biopharma Group’s Senior Scientist\, Niloofar Ganji\, will explain how to identify these issues\, even when they’re not visible to the naked eye\, and share effective strategies for resolving them. \nThe session will cover key techniques such as Freeze Drying Microscopy (FDM) analysis and understanding collapse temperature\, helping you optimize primary drying conditions and prevent defects before they occur. \nKey Benefits of Attending\nYou’ll discover how to: \n\nIdentify & Classify Lyophilization Defects: Learn best practices for recognizing and naming various defects that can occur during freeze drying.\nUtilize Advanced Analytical Tools: Discover how to use instruments like MicroPress to detect defects that aren’t visible to the naked eye or reflected in standard performance assays.\nFix & Optimize: Understand how to rectify identified issues using cutting-edge tools like Lyostat5 and Lyotherm3 to pinpoint necessary process adjustments.\n\nand receive: \n\nReal-World Insights: Gain valuable takeaways from an in-depth case study demonstrating practical solutions.\nInteractive Q&A: Get your questions answered by an expert in the field.\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/when-lyocakes-go-bad-how-to-identify-fix-it/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/when-lyocakes-go-bad-how-to-identify-fix-it/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260915T100000
DTEND;TZID=America/Los_Angeles:20260915T110000
DTSTAMP:20260831T170343Z
CREATED:20260817T165621Z
LAST-MODIFIED:20260831T170343Z
UID:10001159-1789466400-1789470000@www.califesciences.org
SUMMARY:Exploring New Frontiers in In Vivo CAR-T Therapy
DESCRIPTION:Live Webinar: Exploring New Frontiers in In Vivo CAR-T Therapy \n📅 Date: Sept 15\, 2026\n🕙 Time: 10 AM PT | 1 PM ET | 5 PM GMT | 7 PM CET \nFeatured Talk 1: “Targeted-LNP Technology for Precision Genetic Medicine” – Joe Yu\, PhD\nThis talk will introduce practical strategies to overcome these bottlenecks and optimize tLNP development from early-stage discovery to scalable manufacturing. \nFeatured Talk 2: “From Delivery Vehicle to Cells: Enabling In Vivo CAR Development with Integrated End-to-End Solutions” – Hui Yu\, PhD\nExplore integrated solutions for targeted delivery\, LNP characterization\, and CAR detection to accelerate next-generation in vivo CAR therapy development. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/exploring-new-frontiers-in-in-vivo-car-t-therapy/
LOCATION:Virtual
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260915T110000
DTEND;TZID=America/Los_Angeles:20260915T120000
DTSTAMP:20260820T211046Z
CREATED:20260820T211046Z
LAST-MODIFIED:20260820T211046Z
UID:10001161-1789470000-1789473600@www.califesciences.org
SUMMARY:The Regulatory Foundation: Getting It Right Before You Build
DESCRIPTION:For early-stage MedTech founders\, regulatory strategy isn’t a late-stage checkbox\, it’s a foundational decision that shapes everything downstream\, from your FDA pathway to your funding story to how you eventually get paid. \nIn this fireside conversation\, former FDA reviewer Sam Murray walks through the decisions that matter most before you build. We’ll cover how your intended use and your own claims define your regulatory reality\, how to read your risk class and map the right pathway (510(k)\, De Novo\, or PMA)\, the low-cost early moves that get you FDA’s read before you’re locked in\, and what SBIR/STTR reviewers actually want to see in your commercialization plan. We’ll close with why regulatory and reimbursement timing should be planned together and how getting it right early is the cheapest course-correction there is. \nBring your questions for a live audience Q&A to wrap. \nREGISTER» \nAbout the Speakers\nSam Murray\, Head of Regulatory & Quality\, PRIA Healthcare\nSam leads PRIA’s regulatory affairs and quality division\, providing strategic leadership to life sciences and medical device companies navigating complex regulatory pathways and quality system challenges. He advises executive leadership teams\, investors and diligence teams\, product development organizations\, and regulatory and quality leaders on regulatory strategy\, global product approvals\, and scalable quality system design across the full product lifecycle. \nSam’s background spans medical devices\, diagnostics\, combination products\, and software-enabled technologies. His primary areas of expertise include U.S. regulatory strategy\, global regulatory submissions including European MDR and IVDR implementation\, quality system development and remediation\, design controls\, risk management\, and regulatory authority engagement. He has led and supported regulatory programs that enabled global marketing authorizations and reduced time to commercialization. In addition to founding and leading an independent regulatory and quality consultancy supporting medical device manufacturers globally\, Sam has also held senior leadership roles at Advanced Instruments and Formlabs\, where he built and scaled global regulatory and quality organizations\, established multi-site quality systems\, and led acquisition due diligence\, assessing regulatory risk\, quality system maturity\, and post-close integration needs. Sam previously served as a medical device investigator with the U.S. Food and Drug Administration\, conducting domestic and international inspections and driving compliance and enforcement actions. \n​Suzy Engwall\, Senior Director\, Global Business Development and Strategic Growth\, PRIA Healthcare\nSuzy is a healthcare innovation and commercialization executive\, who has spent nearly two decades helping MedTech companies navigate the complex journey from product development to market adoption. She has extensive experience across the MedTech ecosystem\, spanning startups\, accelerators\, health systems\, GPOs\, and international markets\, connecting clients with strategic guidance and expertise they need to successfully commercialize their technologies. \nBefore joining PRIA\, Suzy founded and led HealthTech Strategies\, a consulting firm specializing in U.S. market entry strategy\, GPO contracting\, and commercialization. She previously served as VP of Early MedTech Development at Alira Health\, advising emerging MedTech companies on clinical and commercial strategy. As National Director of the Innovation Lab at the Innovation Institute\, she managed a multi hospital innovation program that brought 21 products to market\, including licensing agreements with CVS and OrthoPediatrics. She designed and facilitated accelerator-style programming\, including hackathons\, innovation sprints\, and pitch showcases\, and guided participants through the process of refining\, patenting\, and launching their inventions. \nA recognized thought leader and speaker across the MedTech ecosystem\, Suzy has served as director and mentor for the Founder Institute HealthTech program\, was on advisory boards for ASU’s Edson College of Nursing and Health Innovation\, the UC Riverside Design Thinking Program\, and currently serves on multiple startup advisory boards\, including the Board of Directors of Actuated Medical. \nHosted by:
URL:https://www.califesciences.org/event/the-regulatory-foundation-university-lab-partners/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/the-regulatory-foundation-university-lab-partners/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260915T110000
DTEND;TZID=America/Los_Angeles:20260915T140000
DTSTAMP:20260727T194655Z
CREATED:20260727T194655Z
LAST-MODIFIED:20260727T194655Z
UID:10001133-1789470000-1789480800@www.califesciences.org
SUMMARY:Scientist.com's Vendor Discovery Day - San Francisco
DESCRIPTION:Join Scientist.com for our 2026 San Francisco Vendor Discovery Day and showcase your innovations! Connect with top researchers\, expand your network and elevate your brand’s visibility. Don’t miss this opportunity to unlock new collaborations and drive your business forward. See you in September! \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/scientist-coms-vendor-discovery-day-san-francisco/
LOCATION:685 Gateway Blvd\, 685 Gateway Blvd\, South San Francisco\, CA\, 94080
CATEGORIES:Industry Collaboration & Networking,Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260915T160000
DTEND;TZID=America/Los_Angeles:20260915T180000
DTSTAMP:20260827T210900Z
CREATED:20260827T210900Z
LAST-MODIFIED:20260827T210900Z
UID:10001177-1789488000-1789495200@www.califesciences.org
SUMMARY:Simbiosyx: Matching Startups with Verified Experts to fuel Innovation
DESCRIPTION:Join us for the matchmaking between startups and experts Simbiosyx Showcase Event\, where innovation meets expertise. Startups will take the stage to present bold ideas and real-world challenges—seeking expert collaborators to help them grow. \nWe’re thrilled to announce the launch of Simbiosyx—Aquillius’ new AI-powered platform designed to connect startups with the expert to support them in their needs and grow. \nStartups can now enter their company details and get matched with pre-vetted experts across industries like biotech\, medtech\, sustainability\, and AI. Whether you’re seeking scientific insight\, regulatory guidance\, or technical expertise\, Simbiosyx makes collaboration seamless. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/simbiosyx-showcase/
LOCATION:10918 Technology Pl. San Diego CA 92127\, 10918 Technology Pl.\, San Diego\, CA\, 92127\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260916
DTEND;VALUE=DATE:20260918
DTSTAMP:20260603T233444Z
CREATED:20260603T233444Z
LAST-MODIFIED:20260603T233444Z
UID:10001097-1789516800-1789689599@www.califesciences.org
SUMMARY:Cell & Gene Therapy Symposium
DESCRIPTION:
URL:https://www.califesciences.org/event/cell-gene-therapy-symposium/
LOCATION:Salk Institute for Biological Studies\, 10010 N Torrey Pines Rd\, La Jolla\, CA\, 92037\, United States
CATEGORIES:California Life Sciences,Industry Collaboration & Networking,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2026/06/Cell-Gene-Therapy.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260916T080000
DTEND;TZID=America/Los_Angeles:20260916T090000
DTSTAMP:20260820T212315Z
CREATED:20260820T212315Z
LAST-MODIFIED:20260820T212315Z
UID:10001165-1789545600-1789549200@www.califesciences.org
SUMMARY:Regulatory Shifts Ahead: Preparing for FDA Changes and EU Pharmaceutical Reform
DESCRIPTION:Regulatory change is underway on two fronts. FDA review practice has evolved meaningfully over recent review cycles\, and the EU has finalized a sweeping reform of its pharmaceutical legislation that has not yet entered into force. For sponsors filing an IND with the FDA\, preparing an EMA submission\, or planning a Phase II expansion into the EU\, this session offers an early look at what’s changing and how to get ahead of it. \nIn this session\, William Lian (BioDuro) covers the current FDA IND landscape: where IND submission changes\, how Clinical Holds get resolved\, and why getting CMC right early is the key to avoiding them. William will also introduce FDA’s evolving expectations for nonclinical development\, including initiatives such as the increased use of New Approach Methodologies (NAMs). \nMiranda van Bodegom (DADA Consultancy) turns to the EU\, where the change is legal\, not procedural. She unpacks several developments under what EMA itself has called “the most significant overhaul of the regulatory framework in over two decades”. Miranda will introduce upcoming changes covering development and registration phases\, pharmacovigilance and regulatory aspects\, the new approach to environmental risk\, and the expanded the use of Master Files. \nJoin BioDuro and DADA Consultancy to find out what’s changing\, and what sponsors should be preparing for. \nWhat you will learn: \n\nWhy FDA Clinical Holds happen\, and how CMC readiness prevents them\nWhether FDA’s NAMs shift changes your preclinical testing plan\nWhether you qualify for a Master File under the EU’s pharmaceutical legislation reform\nHow to navigate the European “green legislation”\nHow to position your pipeline now\, ahead of these changes taking full effect\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/preparing-for-fda-changes-and-eu-pharmaceutical-reform/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/preparing-for-fda-changes-and-eu-pharmaceutical-reform/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260916T110000
DTEND;TZID=America/Los_Angeles:20260916T140000
DTSTAMP:20260827T204920Z
CREATED:20260827T204920Z
LAST-MODIFIED:20260827T204920Z
UID:10001175-1789556400-1789567200@www.califesciences.org
SUMMARY:MBC BioLabs Fall Life Science Vendor’s Showcase
DESCRIPTION:Join us for our Fall Life Science Vendor Showcase\, bringing together innovative scientific and business solutions tailored for early-stage biotech teams. Meet industry experts\, explore new technologies\, and discover tools that can accelerate your work at MBC BioLabs. \n🍁 What to Expect\nDiscover Solutions for Startups\nExplore tools and services designed to support drug discovery\, molecular biology\, genomics\, instrumentation\, operational efficiency\, and company growth. \nLunch Included\nPick up your lunch ticket at check-in and enjoy a meal while you explore the showcase. \nMeet New Partners & Build Your Network\nConnect with leading vendors who offer cutting-edge technologies and services to strengthen your R&D pipeline. \n👥 Who Should Attend\nThis showcase is ideal for: \n\nFounders and early-stage biotech teams\nResearch associates and bench scientists\nPlatform\, screening\, and discovery scientists\nOperations\, lab managers\, and procurement teams\nAnyone looking to evaluate new tools\, technologies\, or service providers that support R&D and company growth\n\n🚗 Parking Information\nPlease note that there is limited parking available at 1030 Brittan Ave. Limited street parking may be available in the surrounding neighborhood. We strongly encourage attendees to plan ahead and consider public transit or rideshare options for an easier arrival. \n🧪 Participating Vendors\n\nAgilent Technologies\nBiocom\nBionova Scientific\nBioIVT\nChemPartner\nClutch Biotechnologies\nEurofins Viracor BioPharma\nKACTUS\nKaironexus Innovations Inc.\nNovogene Corporation Inc.\nRevvity\nScience Exchange (HappiLabs)\nSignios\nSino Biological\nSony Biotechnology Inc.\nSynfini\, Inc.\nTargetMol Chemicals\nTecan\nVazyme Biotech\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/mbc-biolabs-fall-life-science-vendors-showcase/
LOCATION:1030 Brittan Ave\, 1030 Brittan Ave\, San Carlos\, CA\, 94070\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260917T080000
DTEND;TZID=America/Los_Angeles:20260918T170000
DTSTAMP:20260625T182515Z
CREATED:20260625T182515Z
LAST-MODIFIED:20260625T182515Z
UID:10001115-1789632000-1789750800@www.califesciences.org
SUMMARY:PCC West | Pharmaceutical Compliance Congress West
DESCRIPTION:Transform your compliance strategy at PCC West – the West Coast’s most dynamic gathering of life science compliance leaders. This September 10-11 at Hilton La Jolla in San Diego\, immerse yourself in cutting-edge insights that will revolutionize how you navigate today’s complex regulatory landscape. Discover game-changing strategies for FDA compliance\, master DOJ enforcement trends\, and unlock the potential of AI while mitigating risks. Engage with visionary experts tackling real-world challenges in HCP engagement\, patient interactions\, and program optimization. You’ll leave equipped with actionable intelligence and powerful connections that elevate your compliance program from reactive to revolutionary. \n\nCLS members receive a 10% discount on registration for the event. Contact your account manager or reach out to bd@califesciences.org for more information. \n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/pcc-west-2026/
LOCATION:HILTON LA JOLLA TORREY PINES\, 10950 N. Torrey Pines Road\, La Jolla\, CA\, 92037\, United States
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260917T083000
DTEND;TZID=America/Los_Angeles:20260917T173000
DTSTAMP:20260820T210651Z
CREATED:20260820T210651Z
LAST-MODIFIED:20260820T210651Z
UID:10001160-1789633800-1789666200@www.califesciences.org
SUMMARY:Small Molecule Human PK and Dose Projection
DESCRIPTION:Join us for a comprehensive\, full-day workshop dedicated to the fundamentals and latest advancements in human pharmacokinetics (PK) and dose prediction for small molecules. This intensive event brings together leading industry experts to share scientific principles and practical strategies for translating in vitro and preclinical data to project human efficacious dose. \nThe sessions will first focus on fundamental PK parameter predictions\, covering topics such as human clearance in vitro-to-in vivo extrapolation (IVIVE)\, allometric scaling approaches\, human volume of distribution prediction\, and oral absorption\, alongside an in-depth discussion of transporter-mediated hepatobiliary and renal clearance. The workshop will also cover the integration of predicted human PK parameters and PKPD relationship to project human efficacious dose using modeling approaches\, ranging from classic compartmental models to physiologically-based PK (PBPK) and systems pharmacology models. The afternoon sessions will pivot toward human PK and dose prediction for emerging new modalities\, such as peptides and strategic design of First-in-Human (FIH) studies. Concluding with an interactive panel discussion featuring all speakers\, this workshop offers DMPK scientists\, pharmacologists\, and translational researchers a valuable platform to gain actionable insights and discuss the challenges of modern small molecule and new modality drug discovery and development. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/small-molecule-human-pk-and-dose-projection/
LOCATION:Hilton San Francisco Airport Bayfront\, 600 Airport Blvd\, Burlingame\, CA\, 94010\, United States
CATEGORIES:Industry Events
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260917T120000
DTEND;TZID=America/Los_Angeles:20260917T130000
DTSTAMP:20260824T155619Z
CREATED:20260824T155619Z
LAST-MODIFIED:20260824T155619Z
UID:10001168-1789646400-1789650000@www.califesciences.org
SUMMARY:From drug target discovery to clinical translation: Olink solutions bring value to your pipeline
DESCRIPTION:Unlocking complex disease biology requires high-sensitivity tools that work with ultra-low sample volumes. Join University Lab Partners and Olink Proteomics for an exclusive Lunch & Learn exploring how Proximity Extension Assay technology is advancing precision oncology and biomarker discovery. \nWe are honored to feature guest speaker Liya Xu\, PhD (USC Keck School of Medicine / Children’s Hospital Los Angeles)\, who will present ground-breaking research on using eye fluids as liquid biopsies to understand cancer biology. \nAgenda Highlights\nFeatured Talk: Compartmental Liquid Biopsy: Aqueous Humor as a Window into Ocular Cancer Biology \nSpeaker: Liya Xu\, PhD (Assistant Professor of Research Ophthalmology\, USC Keck School of Medicine; PI\, Aqueous Humor Laboratory\, CHLA) \nWhat You’ll Learn: \n\nHow to screen up to 5\,400 protein biomarkers using as little as 2 µL of sample\nApplications of PEA technology in challenging matrices like aqueous humor and tears\nScalable workflows: From custom disease panels to broad population screening\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/from-drug-target-discovery-to-clinical-translation/
LOCATION:5270 California Ave\, 5270 California Ave\, Irvine\, CA\, 92617\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260917T150000
DTEND;TZID=America/Los_Angeles:20260917T173000
DTSTAMP:20260903T214610Z
CREATED:20260903T214610Z
LAST-MODIFIED:20260903T214610Z
UID:10001184-1789657200-1789666200@www.califesciences.org
SUMMARY:Perspectives in STEM: Developing & Harnessing Local Talent
DESCRIPTION:This seminar will explore how local biotech partnerships help identify\, develop\, and retain scientific talent across every stage of a career — from internships and early research experience\, through advanced training\, to faculty-industry collaboration. Panelists will share personal journeys and highlight existing programs and mechanisms for getting involved\, offering attendees concrete pathways for engaging with industry. \nDeveloping and Harnessing Local Talent — Discussions will focus on the different “entry points” into biotech (internship/undergraduate\, post-graduate training\, and faculty-level engagement)\, and how regional partnerships and licensing collaborations help drive innovation by growing local talent. \nHosted by Johnson & Johnson La Jolla Campus\, in collaboration with Scripps Research Translational Institute\, Scripps Research Education & Training\, San Diego State University\, and UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences. \nPerspectives in STEM is a cross-institution collaboration (SRTI\, Skaggs Graduate School\, UC San Diego\, SDSU\, and Johnson & Johnson) that designs high-impact networking and quarterly seminar experiences connecting students\, trainees\, faculty\, clinicians\, and industry leaders since 2024. We spotlight inclusive science\, accelerate career pathways\, and build durable partnerships across academia\, health systems and industry through structured networking occasions and practitioner seminar panels that convert ideas into opportunities. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/perspectives-in-stem-developing-harnessing-local-talent/
LOCATION:Johnson & Johnson\, 3210 Merryfield Row\, San Diego\, CA\, 92121\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260921T083000
DTEND;TZID=America/Los_Angeles:20260921T153000
DTSTAMP:20260715T194659Z
CREATED:20260715T194659Z
LAST-MODIFIED:20260715T194659Z
UID:10001125-1789979400-1790004600@www.califesciences.org
SUMMARY:From the Laboratory to Leadership | Virtual
DESCRIPTION:In the life sciences\, technical expertise often leads to a promotion into management. But leading people requires an entirely new set of skills\, and even your highest-performing scientists can struggle without the right support.  \nFrom the Laboratory to Leadership was designed specifically for this critical transition. Across four interactive sessions\, participants learn to:  \n\nDiscover and develop their leadership strengths  \n\n\nLead confidently in dynamic\, fast-paced environments  \n\n\nRun effective meetings and coach for performance  \n\n\nSet expectations\, delegate effectively\, and adapt to different personality styles  \n\n\nAmplify the performance outcomes of their teams \n\nProgram dates: September 21\, October 5\, October 19\, November 2 \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/lab-to-leadership-virtual-2026/
CATEGORIES:Industry Events,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/lab-to-leadership-virtual-2026/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260922
DTEND;VALUE=DATE:20260924
DTSTAMP:20260727T203342Z
CREATED:20260727T203342Z
LAST-MODIFIED:20260727T203342Z
UID:10001137-1790035200-1790207999@www.califesciences.org
SUMMARY:RESI Boston 2026
DESCRIPTION:RESI Boston 2026\, a key component of Biotech Week Boston\, will take place on September 22-23 at the Westin Copley Place\, followed by three days of virtual partnering on September 25\,28-29. This hybrid format combines the benefits of in-person networking with the flexibility of online interactions. \n\nThrough August 14\, the California Life Sciences community can save an additional $200 on RESI Boston registration. Contact your account manager or reach out to bd@califesciences.org for more information. \n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/resi-boston-2026/
LOCATION:Westin Copley Place\, 10 Huntington Ave\, Boston\, MA\, 02116\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2026/02/Beyond-California-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260922T103000
DTEND;TZID=America/Los_Angeles:20260922T113000
DTSTAMP:20260824T160149Z
CREATED:20260824T160149Z
LAST-MODIFIED:20260824T160149Z
UID:10001169-1790073000-1790076600@www.califesciences.org
SUMMARY:How to Manage Your Board Meetings and Reporting Processes
DESCRIPTION:Join University Lab Partners and Ryan Keating\, Partner at EisnerAmper\, for an in-depth webinar designed to help startup founders and emerging life sciences companies build board meeting and reporting practices that strengthen investor relationships and support smarter decision-making. \nYour board is one of your most valuable resources\, but only if you know how to run it well. Establishing clear\, repeatable processes early helps you keep investors aligned\, surface issues before they escalate\, and get real value from the people around your table. \nWhat You’ll Learn\n\nHow to structure an effective board meeting and set the right agenda\nWhat financial and operational metrics to include in your board reporting\nHow to prepare materials that keep investors informed and engaged\nPractical steps to turn board meetings into a strategic advantage\n\nAbout our Speaker\nRyan Keating\, Partner\, Eisner Advisory Group LLC \nRyan is a Partner in the firm’s Outsource Accounting Services practice. He has advised and worked with more than 120 early-stage venture capital- seeking and venture-backed companies\, several as the interim CFO. Ryan possesses an extensive financial and management consulting background from more than 20 years with venture backed companies and large technology and management consulting firms including Microsoft\, Salomon Smith Barney and PricewaterhouseCoopers. \n​Prior to Joining EisnerAmper\, Ryan was the Founder and Managing Partner of Keating Consulting Group\, a Silicon Valley-based financial professional services firm. Keating Consulting Group helped implement and manage essential function areas necessary to support early-stage companies and VC-backed startups by offering interim CFO services\, financial leadership and a full suite of accounting\, HR\, and back-office support services. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/manage-your-board-meetings-and-reporting-processes/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/manage-your-board-meetings-and-reporting-processes/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260922T120000
DTEND;TZID=America/Los_Angeles:20260922T130000
DTSTAMP:20260831T160907Z
CREATED:20260831T160531Z
LAST-MODIFIED:20260831T160907Z
UID:10001181-1790078400-1790082000@www.califesciences.org
SUMMARY:State of the Venture Capital Financing Market - Day 1
DESCRIPTION:Paul Hastings LLP is hosting a 2-day series at MBC BioLabs on September 22\, 2026 (1030 Brittan Ave\, San Carlos) and September 23\, 2026 (135 Mississippi St\, SF). \nPlease join us for a discussion of the current state of the venture capital market financing and a Q&A session with VCs from the Bay Area life sciences community. \nModerator: James Huie\, Paul Hastings LLP \nSpeakers: \nColin Walsh\, PhD\, Goldman Sachs Alternatives\nColin Walsh\, PhD is a Managing Director and Senior Investor on the Life Sciences Investing team within Goldman Sachs Alternatives. Prior to joining the firm\, Colin was a Partner at Qiming Venture Partners USA. He has more than ten years of experience working as an investor and operator in early-stage life sciences companies. Colin earned dual BS degrees in Chemical Engineering and Biochemistry from the University of Massachusetts\, Amherst\, and a PhD from the UC Berkeley-UCSF Graduate Program in Bioengineering. \nZach Collins\, PhD\, MBC Capital\nZach Collins\, PhD is a Partner in Mission BioCapital’s San Francisco office. He focuses on investments in early-stage biopharmaceutical companies and launching early-stage company operations in collaboration with entrepreneurs at times through interim executive roles. He holds board roles at Cavalry Biosciences\, Nuvig Therapeutics\, Jupiter Bioventures\, and additional early-stage portfolio companies. Zach served on the board of SiteOne Therapeutics through its 2025 acquisition by Eli Lilly for up to $1B. At MBC Biolabs\, Zach supports startups as an Entrepreneur Success Partner. His training is in molecular biology & genetics. While at Harvard Medical School\, Zach co-authored work that was recognized by Science as 2018’s Breakthrough of the Year. Zach holds a Ph.D. in Biological and Biomedical Sciences from Harvard University and a B.S. in Biology from George Washington University. \nAlexis Ji\, Primer Ventures\nDr. Alexis Ji is the Founding Partner of Primer Ventures\, leveraging her two decades of expertise in research and investment in the biopharmaceutical and genomics industries. Primer Ventures is a venture capital firm investing in early-stage companies in the fields of life science tools and diagnostics\, innovative therapeutics\, and digital health. It provides early capital to empower visionary entrepreneurs in translating cutting-edge science and technologies into transformative products. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/state-of-the-venture-capital-financing-market-day-1/
LOCATION:1030 Brittan Ave\, 1030 Brittan Ave\, San Carlos\, CA\, 94070\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260922T120000
DTEND;TZID=America/Los_Angeles:20260922T160000
DTSTAMP:20260817T172155Z
CREATED:20260817T165348Z
LAST-MODIFIED:20260817T172155Z
UID:10001158-1790078400-1790092800@www.califesciences.org
SUMMARY:Discovery Bites 2026: Structural Biology in the Age of AI
DESCRIPTION:Discovery Bites 2026 is an invitation-based working lunch hosted by IRBM during Biotech Week Boston\, held inside the Harvard Art Museums. \nTopic: Structural Biology in the Age of AI. The Power of NMR Experimental Data for Smarter Drug Discovery. \nAI-driven drug discovery is only as powerful as the data behind it. As AI and structure prediction tools reshape the field\, NMR remains a uniquely powerful technique for revealing molecular insights that no other method can match. Alessandro Piai\, PhD MBA\, Head of Structural Biology at IRBM\, will speak for around 45 minutes before opening the floor to questions and discussion. \nProgram: 12:00 pm arrival and lunch\, 1:00 pm presentation\, 1:45 pm Q&A\, 2:00 pm networking.\nGuests are then welcome to explore the museum galleries. \nWho should attend: research leaders accountable for go/no-go decisions on lead and candidate series\, structural biologists and biophysicists prioritizing limited instrument time\, and CSOs\, founders and R&D executives assessing whether structural work is mission-critical. \nThere is no fee to attend. Places are limited and confirmed on a rolling basis. Registration closes September 4\, 2026. \nREGISTER \nContact: Michael Ziebell\, PhD\, Assoc. Director Business Development\, m.ziebell@irbm.com\, +1 781 579 0436.
URL:https://www.califesciences.org/event/discovery-bites-2026-structural-biology-in-the-age-of-ai/
LOCATION:Harvard Art Museum\, 32 Quincy St\, Cambridge\, MA\, 02138
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2026/02/Beyond-California-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260923T120000
DTEND;TZID=America/Los_Angeles:20260923T130000
DTSTAMP:20260831T160841Z
CREATED:20260831T160841Z
LAST-MODIFIED:20260831T160841Z
UID:10001182-1790164800-1790168400@www.califesciences.org
SUMMARY:State of the Venture Capital Financing Market - Day 2
DESCRIPTION:Paul Hastings LLP is hosting a 2-day series at MBC BioLabs on September 22\, 2026 (1030 Brittan Ave\, San Carlos) and September 23\, 2026 (135 Mississippi St\, SF). \nPlease join us for a discussion of the current state of the venture capital market financing and a Q&A session with VCs from the Bay Area life sciences community. \nModerator: Matt Kovac\, Paul Hastings LLP \nSpeakers: \nLandon Merrill\, Genoa Ventures\nLandon is a Partner at Genoa Ventures where he brings world-class skills in structured\, rigorous product strategy and development to deal diligence and portfolio company support. With a wide range of technical and commercial leadership experience in organizations ranging from startups to multinationals\, from life science tools to pharma discovery platforms\, Landon brings a diverse set of experiences and a keen ability to identify opportunities for cross-pollination. Landon started his career as a founding team member of a small start-up in Boston. While leading application development for this team and earning his masters degree in genetics\, he had the opportunity to teach at UMass-Boston\, where he fell in love with communicating scientific content and educating. After moving to Harvard Partners Center for Personalized Genomic Medicine to help establish an NGS sequencing core\, he led technology and process development efforts for an encoded library technology platform at GlaxoSmithKline. Landon continued to teach at UMass-Boston through his subsequent product development time at New England Biolabs\, right through moving to the Bay Area to be a founding team member of 10X Genomics. At 10X Genomics Landon initially worked on the development of the GemCode assays\, but quickly moved on to managing customer engagement and ultimately the commercial launch of the platform. He also spent time at Purigen Biosystems to lead the Product Management and Corporate Strategy efforts\, and Synthomics leading Commercial Operations. Landon has an MSc in Genetics from the University of Massachusetts-Boston and a BS from Connecticut College. He joined Genoa to leverage his chimeric experience to help build stronger and more resilient ventures that aim to bring transformative technologies to market. Landon loves nothing more than getting to know founding teams and helping them develop clarity around a vision and strategy that can be translated into action. \nAmanda Cashin\, Wing VC\nAmanda Cashin\, PhD is a driven life science venture investor\, company builder\, entrepreneur\, and industry executive. Dr. Cashin is currently an investment Parter at Wing Venture Capital\, where she is focused on early-stage therapeutics investments\, including innovative medicines in oncology and immunology. Most recently\, Dr. Cashin co-founded and was CEO of Prisma Bio\, a breakthrough optical protein-sequencing company. Previously\, Dr. Cashin co-founded and was Global Head of Illumina For Startups & Illumina Accelerator – a founding investor in 74 startups across therapeutics\, synbio\, tools\, diagnostics & agtech. Previously\, she was Senior Vice President of Alexandria Venture Investments where she led the strategic corporate venture capital arm of Alexandria Real Estate Equities\, Inc. She earned a Ph.D. in Chemical Biology from the California Institute of Technology and graduated summa cum laude with a Bachelor’s degree in Physical Organic Chemistry from the University of Colorado\, Boulder. \nPo Bronson\, SOSV\nPo is a General Partner at SOSV and Managing Director of SOSV SF. He is passionate about reconceptualizing complex challenges into more elegant forms in order to broaden understanding and highlight priorities. Po is a longtime science journalist honored with nine national awards\, and author of seven bestselling books that are available in 28 languages worldwide. His work has been cited in 185 academic journals and 503 books. His background is in Economics. He learned finance at Credit Suisse and consulting at a division of Arthur Andersen. Prior to IndieBio he spent four years as a Futurist with Attention Span Media\, consulting corporate innovation efforts for globally recognized brands. Most recently\, Po is the author of Decoding the World: A Roadmap for the Questioner\, published by Twelve Books\, a division of the Hachette Publishing Group. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/state-of-the-venture-capital-financing-market-day-2/
LOCATION:135 Mississippi St\, 135 Mississippi St\, San Francisco\, CA\, 94118\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260923T173000
DTEND;TZID=America/Los_Angeles:20260923T203000
DTSTAMP:20260817T163554Z
CREATED:20260817T163226Z
LAST-MODIFIED:20260817T163554Z
UID:10001154-1790184600-1790195400@www.califesciences.org
SUMMARY:San Diego EDC Summer Bash
DESCRIPTION:Local summer is just getting started! Join San Diego Regional EDC\, Alexandria Real Estate Equities\, Inc.\, NOVO Brazil Brewing Co.\, and a few hundred friends for EDC’s seventh annual Summer Bash on September 23. You’ll enjoy meaningful networking\, live music\, and local bites and drinks —all at Casa at Campus Point by Alexandria. \nREGISTER
URL:https://www.califesciences.org/event/san-diego-edc-summer-bash/
LOCATION:CASA Campus Point\, 4242 Campus Point Ct\, San Diego\, CA\, 92121
CATEGORIES:Community Initiatives & Programs,Industry Collaboration & Networking
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260924T100000
DTEND;TZID=America/Los_Angeles:20260924T110000
DTSTAMP:20260827T211322Z
CREATED:20260827T211322Z
LAST-MODIFIED:20260827T211322Z
UID:10001179-1790244000-1790247600@www.califesciences.org
SUMMARY:Optimizing Cell Culture for Immune Cell Therapy Manufacturing
DESCRIPTION:Efficient in vitro culture of immune cells is essential for cell and gene therapy development. However\, different immune cell types have unique metabolic and cytokine requirements\, making a one-size-fits-all culture medium challenging. This webinar introduces a flexible two-component medium system designed to support the specific needs of different immune cell types. \nHighlights: \n\nFlexible two-component system with a universal basal medium and customized supplements\nBroad immune cell compatibility for T cells\, NK cells\, and γδ T cells\nHigh expansion performance: up to 3\,000-fold for T cells\, 1\,000-fold for NK cells\, and 17\,600-fold for γδ T cells\nHigh cell purity: 99% T cells\, 97% NK cells\, and 93% γδ T cells\nStreamlined optimization to improve efficiency in immune cell therapy development\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/optimizing-cell-culture-for-immune-cell-therapy-manufacturing/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/optimizing-cell-culture-for-immune-cell-therapy-manufacturing/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260924T173000
DTEND;TZID=America/Los_Angeles:20260924T223000
DTSTAMP:20260824T154957Z
CREATED:20260824T154957Z
LAST-MODIFIED:20260824T154957Z
UID:10001166-1790271000-1790289000@www.califesciences.org
SUMMARY:The Endpoints 11: biopharma’s most promising startups in 2026
DESCRIPTION:True innovation has never been harder to see. \nNew financial models are changing how and where new drugs get developed. Promising molecules draw a dozen copycats right out the gate. The genuinely risky\, boundary-pushing work often happens behind closed doors. \nEndpoints editors sifted through the muddle to uncover eleven companies whose work clears the bar. These are the groups building the tools and making the scientific advances that help the industry take leaps forward. \nEndpoints 11 is more than a list. It’s a night where founders\, investors and the editors who follow them come together in one room. \nThe Endpoints 11 virtual experience\nWatch the highlights from the gala’s fireside chat and editorial introductions\, then go deeper with winner interviews and conversations with the Endpoints editors behind the selections. Free to register. \nAgenda to be announced.\nThe virtual day brings you inside the story: winner interviews\, bonus content\, and conversations with the Endpoints editors who selected this year’s cohort. \nWant to be in the room for the unveiling? Reserve your spot for the in-person gala dinner. \nThe gala is in-person only\, and intentionally intimate. Held at the iconic State Room in Boston\, it’s where you’ll hear from the 11 companies first\, then spend the evening in conversation with the founders building them\, the investors backing them and the journalists who chose them. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/endpoints-11-in-person/
LOCATION:The State Room\, 60 State Street\, 33rd Floor\, Boston\, MA\, 02109\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2026/02/Beyond-California-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260925T150000
DTEND;TZID=America/Los_Angeles:20260925T180000
DTSTAMP:20260903T215600Z
CREATED:20260903T215600Z
LAST-MODIFIED:20260903T215600Z
UID:10001187-1790348400-1790359200@www.califesciences.org
SUMMARY:SD Biotech Community Pickle Ball Happy Hour
DESCRIPTION:Have fun with colleagues & network with your favorite life science suppliers. No experience required. Everyone is welcome. Enjoy beer & wine\, tasty appetizers\, and music with a LIVE DJ. \nEvent attendance is FREE. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/sd-biotech-community-pickle-ball-happy-hour/
LOCATION:4110 Campus Point Court\, 4110 Campus Point Court\, San Diego\, CA\, 92122\, United States
CATEGORIES:Industry Collaboration & Networking
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260927T070000
DTEND;TZID=America/Los_Angeles:20260927T150000
DTSTAMP:20260615T165457Z
CREATED:20260615T165457Z
LAST-MODIFIED:20260615T165457Z
UID:10001109-1790492400-1790521200@www.califesciences.org
SUMMARY:2026 Tour de Cure®: Northern California
DESCRIPTION:Join the American Diabetes Association® along with your friends\, family\, and colleagues as we ride in support of people living with diabetes. \nTour de Cure® is the moment for corporations\, organizations\, and individuals to come together and show our community how much we care—and how much we’ll do to end diabetes for good. By joining the Tour de Cure fundraising event\, you’ll help us increase awareness\, provide vital programs\, fund lifesaving research\, and work toward a cure. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/2026-tour-de-cure-northern-california/
LOCATION:HP\, Inc.\, 1501 Page Mill Rd.\, Palo Alto\, CA\, 94304
CATEGORIES:Community Initiatives & Programs,Industry Collaboration & Networking,Industry Events
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260928T084500
DTEND;TZID=America/Los_Angeles:20260928T163000
DTSTAMP:20260817T171524Z
CREATED:20260817T163834Z
LAST-MODIFIED:20260817T171524Z
UID:10001155-1790585100-1790613000@www.califesciences.org
SUMMARY:Nonclinical safety pharmacology studies for IND and regulatory filings
DESCRIPTION:This workshop will provide an integrated overview of how safety pharmacology studies support IND‑enabling development\, with a focus on regulatory expectations\, evolving scientific practices\, and translational decision‑making. Topics will begin with an overview of current regulatory guidance and agency expectations for safety pharmacology programs\, setting the framework for study scope\, timing\, and interpretation. \nCore systems safety pharmacology will be addressed in depth\, including nonclinical cardiovascular (CV) safety assessment\, with discussion of study design\, endpoints\, and integration with clinical risk assessment. This will be complemented by a clinical pharmacology perspective on CV safety\, including TQT studies\, criteria for TQT waivers\, and strategies for leveraging nonclinical and early clinical data to support regulatory decisions. \nCentral nervous system (CNS) safety will be covered through focused discussions on seizure liability\, the use of EEGs\, and interpretation of neurophysiologic signals in both discovery and IND‑enabling contexts. Respiratory safety pharmacology will be reviewed\, highlighting standard approaches\, key endpoints\, and relevance to human risk. \nBroader safety pharmacology considerations beyond the core battery will be discussed\, including evaluation of CNS\, brain\, gastrointestinal\, renal\, and related organ system effects\, with emphasis on fit‑for‑purpose study design and data integration. The workshop will conclude with emerging approaches\, featuring novel safety pharmacology studies that have elucidated Nav1.7‑associated dysautonomia\, illustrating how targeted mechanistic assessments can inform clinical safety and enhance translational understanding. \nREGISTER
URL:https://www.califesciences.org/event/nonclinical-safety-pharmacology-studies-for-ind-and-regulatory-filings/
LOCATION:1221 Chess Drive\, 1221 Chess Dr\, Foster City\, CA\, 94404
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260928T110000
DTEND;TZID=America/Los_Angeles:20260928T130000
DTSTAMP:20260706T155445Z
CREATED:20260706T155445Z
LAST-MODIFIED:20260706T155445Z
UID:10001120-1790593200-1790600400@www.califesciences.org
SUMMARY:The Endpoints 11: biopharma’s most promising startups in 2026
DESCRIPTION:True innovation has never been harder to see. \nNew financial models are changing how and where new drugs get developed. Promising molecules draw a dozen copycats right out the gate. The genuinely risky\, boundary-pushing work often happens behind closed doors. \nEndpoints editors sifted through the muddle to uncover eleven companies whose work clears the bar. These are the groups building the tools and making the scientific advances that help the industry take leaps forward. \nEndpoints 11 is more than a list. It’s a night where founders\, investors and the editors who follow them come together in one room. \nThe Endpoints 11 virtual experience\nWatch the highlights from the gala’s fireside chat and editorial introductions\, then go deeper with winner interviews and conversations with the Endpoints editors behind the selections. Free to register. \nAgenda to be announced.\nThe virtual day brings you inside the story: winner interviews\, bonus content\, and conversations with the Endpoints editors who selected this year’s cohort. \nWant to be in the room for the unveiling? Reserve your spot for the in-person gala dinner. \nThe gala is in-person only\, and intentionally intimate. Held at the iconic State Room in Boston\, it’s where you’ll hear from the 11 companies first\, then spend the evening in conversation with the founders building them\, the investors backing them and the journalists who chose them. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/the-endpoints-11-2026/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/the-endpoints-11-2026/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260929T083000
DTEND;TZID=America/Los_Angeles:20261001T151500
DTSTAMP:20260806T202132Z
CREATED:20260806T202111Z
LAST-MODIFIED:20260806T202132Z
UID:10001145-1790670600-1790867700@www.califesciences.org
SUMMARY:Lyophilization Technology Training Workshop: Product\, Process & Systems
DESCRIPTION:Held at UMass Lowell (MA) this 3-day lyophilization technology workshop running from September 29th to October 1st\, 2026\, gives participants a practical and structured overview of the lyophilization process\, from product characterization and formulation considerations through to cycle development\, scale-up and freeze-dryer systems. \nLed by experts in the field of lyophilization from Biopharma Group\, attendees will cover the science\, best practices and engineering behind lyophilization. Through a combination of theoretical sessions and practical workshops\, participants will explore how these principles can be applied to real-life lyo cycle and development questions. \nWhat you’ll learn:\n\nUnderstand the science and best practices behind the lyophilization process\nExplore product characterization methods used before lyophilization cycle development\nReview formulation design strategies for stable lyophilized products\nUnderstand freezing\, primary drying and secondary drying principles\nLearn key considerations for cycle development\, loading and scale-up\nExplore process monitoring\, PAT\, QbD and software-based development approaches\nUnderstand refrigeration\, vacuum\, stoppering and process condenser systems\nEvaluate lyophile appearance\, product analysis\, maintenance and troubleshooting considerations\n\nWhy this course?\nTaught by Dr Kevin Ward and Andrew Ray – Kevin is Biopharma Group’s Director of R&D and has worked in lyophilization since 1993. Andrew is Engineering Manager\, specialising in freeze dryer service\, repair\, installation\, validation and engineering training. \n\nSmall group format with direct access to expert instruction\nCombines lyophilization science\, best practice and engineering knowledge\nCovers product\, process and freeze-dryer system considerations\nIncludes practical workshops and multidisciplinary group exercises\nApplies learning to real-life lyo cycle and development questions\nCertificate of completion provided upon successful completion\n\nWho should attend?\n\nProfessionals working in pharma\, biopharma\, diagnostics\, medical and biotechnology settings\nScientists and engineers using lyophilization from R&D through to manufacturing\nR&D and formulation scientists developing or supporting lyophilized products\nLab managers and technicians involved in freeze-drying processes and analysis\nProduction operatives supporting lyophilization in manufacturing environments\nEngineers and technical support teams working with freeze-dryer systems\nQuality assurance teams supporting product quality and process control\nAnyone seeking a broader understanding of product\, process and system considerations\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/lyophilization-workshop-lowell/
LOCATION:UMass Lowell North Campus\, SAAB Emerging Technology & Innovation Centre (ETIC)\, 40 University Avenue\, Lowell\, MA\, 01854\, United States
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2026/02/Beyond-California-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260929T100000
DTEND;TZID=America/Los_Angeles:20260929T200000
DTSTAMP:20260817T172215Z
CREATED:20260817T165119Z
LAST-MODIFIED:20260817T172215Z
UID:10001157-1790676000-1790712000@www.califesciences.org
SUMMARY:BioscienceLA Week Investor & Innovation Day
DESCRIPTION:Attendees will gain a deeper understanding of the advantages of investing in the Los Angeles bioscience ecosystem\, along with insights into how bioscience companies have successfully navigated the various stages of investment funding. \nThe program will highlight the region’s unique opportunities for private and corporate investors while exploring the resources\, partnerships\, and capital landscape driving innovation. Target attendees include private and institutional investors\, early-stage bioscience companies\, entrepreneurs\, and industry stakeholders. \nREGISTER
URL:https://www.califesciences.org/event/biosciencela-week-investor-innovation-day/
LOCATION:8687 Melrose Ave\, 8687 Melrose Ave\, West Hollywood\, CA\, 90069
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260929T110000
DTEND;TZID=America/New_York:20260929T120000
DTSTAMP:20260820T211647Z
CREATED:20260820T211647Z
LAST-MODIFIED:20260820T211647Z
UID:10001163-1790679600-1790683200@www.califesciences.org
SUMMARY:From Facility to Delivery: Solving the Complex Science of ADC Linker-Payload Synthesis
DESCRIPTION:The rapid growth of antibody-drug conjugate (ADC) programs is creating new challenges for a CDMO execution for highly potent linker-payloads. While containment\, limited material availability\, and accelerated timelines are well-recognized challenges\, successful scale-up and GMP manufacture often depend on solving less frequently discussed problems. These include establishing reference standards when only small quantities of material are available\, managing unusual solubility and physical properties associated with increasingly complex and high-molecular-weight linker-payloads\, establishing industrial hygiene and cleaning limits\, and introducing equipment capable of safely handling highly potent materials without compromising development flexibility or product recovery. \nIn this webinar\, experts from SK pharmteco’s European and North American sites will share practical experience addressing these challenges across the linker-payload development lifecycle—from facility and containment strategy through process and analytical development\, scale-up\, cleaning\, and final product release. Case-based examples will illustrate how integrated chemistry\, engineering\, analytical\, and industrial hygiene strategies can reduce technical risk and support the rapid transition of emerging ADC programs into GMP manufacturing. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/facility-to-delivery-adc-linker-payload-synthesis/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/facility-to-delivery-adc-linker-payload-synthesis/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260930T110000
DTEND;TZID=America/Los_Angeles:20260930T160000
DTSTAMP:20260901T204153Z
CREATED:20260817T164814Z
LAST-MODIFIED:20260901T204153Z
UID:10001156-1790766000-1790784000@www.califesciences.org
SUMMARY:BioscienceLA Week Economic Summit
DESCRIPTION:Featured Programming\nSept. 29: Innovation & Investor Day\nExplore the investment landscape\, commercialization pathways and breakthrough innovations driving the future of life sciences. \nFeatured speakers: \n\nDr. Peter Slavin\, President and CEO\, Cedars-Sinai\nSiegmund Gutman\, Chair of Life Sciences Litigation and co-chair of Patent Litigation\, Mintz\nKwame Ulmer\, Medtech Impact Partners; Venture Partner\, Wavemaker Three-Sixty Health\nRichard Gu\, Vice President\, March Capital\nMichael Einziger\, CEO\, Versicolor Technologies\nFrank Watanabe\, President and CEO\, Arcutis\nPierre Kyme\, Chief Business Officer\, Armata\nMark A. Wisniewski\, Senior Director\, UCLA Technology Development Group\nVanessa Almedro\, Chief Commercialization Officer\, City of Hope\nLoren Martin\, vice provost of Research\, Innovation and Partnerships\, Keck Graduate Institute\n\nSept. 30: Economic Summit\nHear from regional leaders on the policies\, partnerships\, infrastructure and investments that will shape the future growth of Los Angeles’ life sciences economy. \nFeatured speakers include: \n\n\nDr. Gary Michelson\, Co-Founder\, Michelson Philanthropies\nStephanie Hsieh\, CEO\, BioscienceLA\nRhonda Smith\, Executive Director\, California Black Health Network\nRohit Shukla\, CEO\, LARTA Institute\nStephen Cheung\, CEO\, Los Angeles County Economic Development Corp.\nNasim Eftekhari\, Chief AI and Analytics Officer\, City of Hope\nJason D. Hinman\, MD\, PhD\, FAHA\, professor of neurology\n\n\nOct. 1: Career Day\nDesigned for middle and high school students from across Los Angeles\, Career Day will introduce the next generation to the many educational and professional pathways available within the life sciences. Programming will feature the Amgen Biotech Experience and additional hands-on activities. \nOct. 2: Legislator Briefing — Private\nAn invitation-only convening will bring together policymakers and industry leaders to discuss the future of California’s life sciences ecosystem. \nHow You Can Help\nBioscienceLA Week is more than an event. It is an opportunity to showcase the strength\, diversity and momentum of the region’s life sciences ecosystem.  Every registration\, introduction and shared post helps strengthen the ecosystem and reinforces Greater Los Angeles’ position as a global destination for life sciences innovation. \nRegister today and help shape the future of bioscience in Los Angeles. \nREGISTER
URL:https://www.califesciences.org/event/biosciencela-week-2026/
LOCATION:717 W. Temple St\, 717 W. Temple St\, Los Angeles
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
END:VCALENDAR